笔者昨日从省物价局了解到，按照国家发展改革委的统一部署，省物价局近日发出通知，从10月8日起降低抗肿瘤、免疫和血液系统类等药品的最高零售价格，共涉及95个品种、745个剂型规格。其中包括国家调整公布的200多个代表剂型规格，平均降价幅度为17%；我省公布的205个补充剂型规格，平均降价幅度为21.6%。

The author yesterday from the provincial price bureau to know,According to the national development and reform commission unified deployment,Provincial price bureau recently issued a circular,From October 8, reduce the resistance of tumor/The immune and blood system drugs such as the highest retail price,Inoled a total of 95 varieties/745 dosage form specification.Including national adjustment published more than 200 delegates dosage form specification,The average price cut of 17%;Released in 205 supplementary dosage form specification,The average price cut of 21.6%.

　　此次价格调整，是在开展成本价格调查、专家评审和听取有关方面意见的基础上形成的。按照国家发展改革委的要求，对日费用高的药品加大了降价力度、对日费用低的药品不降价，鼓励价格相对低廉药品的生产供应；对部分临床紧缺的血液制品适当提高了价格；对专利等创新型药品适当控制降价幅度，利用价格杠杆促进药品的研发创新；对原单独定价药品，进一步缩小了与统一定价药品之间的价差，以促进市场公平竞争。

The price adjustment,Is in the development cost price survey/Expert review and listen to the opinions of the formed on the basis of.According to the requirements of the national development and reform commission,The high cost of drugs, to increase the price cut strength/To low cost, the drug is not depreciate,Encourage price are relatively cheap drugs production supply;For some clinical shortage of blood products appropriately raise the price;Such as patent innovative drug properly control the price range,Use the price lever to promote the pharmaceutical research and development innovation;The original single drug pricing,Further narrowed and unified pricing between drug price,In order to promote fair competition in the market.

　　参照上述原则和药品差比价规则，结合广东实际，省物价局对目前在广东市场销售的抗肿瘤、免疫和血液系统类等政府定价药品进行了全面清理，补充制定调整了国家未公布的205个剂型规格的药品价格。此次公布的单独定价药品中，降幅最大的是重组人粒细胞集落刺激因子，从原来的216元调整为120元，降幅达44.5%。通知明确，各医疗卫生机构、社会零售药店及其他药品生产经营单位销售相关药品的价格不得超过本次公布的价格。 (记者/牛思远 通讯员/岳佳综)

With reference to the above principles and drug differential ratio rule,Combined with the actual guangdong,Provincial price bureau to at present in guangdong market sales of antitumor/The immune and blood system such as the government pricing drug for a comprehensive cleaning,Supplement formulated adjusted the country not released 205 specifications of the dosage form drug price.The official alone in drug pricing,Drop the largest is the recombinant human granulocyte colony stimulating factor,From the original 216 yuan to 120 yuan,Drop of 44.5%.Notice clear,The medical and health institutions/Social retail drugstores and other drug production and business operation entities related sales prices of medicines may not exceed the listed price. (Reporter/NiuSiYuan correspondent/YueJia ensemble)